Skip to main content

Table 2 Trial adherence and use of lipid-modifying medication post-trial

From: Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study

Time Treatment Proportion on-treatment (%)
Fenofibrate group Placebo group
Year 1 Fenofibrate/placebo 91.4 91.2
Simvastatin 94.5 95.5
Year 2 Fenofibrate/placebo 88.8 91.5
Simvastatin 93.6 96.1
Year 3 Fenofibrate/placebo 87.2 90.2
Simvastatin 91.3 92.9
Year 4 Fenofibrate/placebo 85.3 86.3
Simvastatin 92.9 92.5
Trial exit visit Fenofibrate/placebo 82.7 86.3
Simvastatin 93.1 91.0
1st post-trial visit Fibrate 7.2 7.4
Stains 77.1 78.4
Last post-trial visit Fibrate 5.4 4.8
Stains 72.0 74.0